AHAhmed Higazy

Ahmed Higazy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ahmed Higazy has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Factors predicting the success of ejaculation preserving transurethral resection of the prostate: a prospective cohort study

    by Ahmed Higazy, Marco Sawiris, Mohamed Kotb, Mohamed Ismail, Ahmed Tawfick, Ahmed Lotfy

  • Open Access

    Holmium versus bipolar en bloc transurethral resection of urinary bladder tumors: a randomized controlled trial

    by Ahmed Higazy, Ahmed Lotfy, A.M. Tawfeek, Ayman Ali, Ahmed Radwan

    The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...

  • Open Access

    Four-year outcomes of water vapor thermal therapy for benign prostatic hyperplasia

    by Ahmed Higazy, Mohammed Zaza, Mohammed Hassan Ali, Mahmoud Elshahawy, Tarek Salem, Samir Azazy, Muhammad Soliman


  • Mini-Endoscopic Combined Intrarenal Surgery vs Percutaneous Nephrolithotomy in the Management of Complex Nephrolithiasis: A Randomized Controlled Trial

    by Ahmed Mohamed Tawfeek, Ahmed Higazy, Moatazbellah Mohamed Elkenany, Khaled Taema, Hisham Arafa

    Objective: To evaluate mini-endoscopic combined intrarenal surgery (mECIRS) vs percutaneous nephrolithotomy (PCNL) in managing complex renal stones. Material and Methods: A randomized controlled study was conducted at our tertiary center between July 2022 and July 2024, involving 100 patients with complex renal stones who were randomly allocated for PCNL or mECIRS. The stone burden was determined based on Guy’s score using a non-contrast computed tomography of the urinary tract; patients with Guy’s Stone Score of III or IV were included in our study. Our primary objective was to assess grade A single session stone-free rate (SS-SFR) in both procedures after 1 month, defined as no stone residual after a single session procedure. Secondary outcomes included grade A (≤2 mm residual), Grade C (2.1–4 mm residual), and overall SFRs, complication rates (per Clavien-Dindo classification), operative time, fluoroscopy time, hospital stay, and overall cost. Results: Patient and stone characteristics were similar in both groups. Grade A SS-SFR revealed a statistically significant difference in favor of the mECIRS group compared with the PCNL group (51% vs 32.6%, respectively, p -value = 0.0275). However, the final grade A SFR after auxiliary procedures was comparable (40.8% for the PCNL group compared with 51% for the ECIRS group, p -value = 0.557). The mECIRS showed a less operative and fluoroscopy time. The complication rate was 38.77% vs 14.28% in the PCNL and mECIRS, respectively, where it was higher in the former, with a statistically significant value ( p -value = 0.006). The mECIRS group experienced shorter hospital stay and comparable cost-effectiveness. Conclusion: mECIRS is effective and safe in managing patients with complex renal stones in a single session with fewer comorbidities than standard PCNL. The study was registered at Clinicaltrial.gov with a registration number: NCT06085794.


  • Open Access

    The outcome of pre-renal transplant bladder cycling in patients with defunctionalized bladder

    by M. Esmat, Ahmed Higazy, Mohamed Shaker, Ahmed Radwan, Mohamed Kandil

    Renal transplantation (RT) continues to be the definitive and most effective treatment for patients with end-stage renal disease (ESRD), offering superior survival and quality of life compared to d...

  • Open Access

    Flexible mini-percutaneous nephrolithotomy versus retrograde intra-renal surgery in the management of renal stones: a randomized controlled trial

    by Ahmed Higazy, M. Kandil, Ahmed Elshafei, M. Esmat, A. M. Tawfeek

    Purpose: To assess the safety, efficacy, and cost-effectiveness of flexible mini-percutaneous nephrolithotomy (F-mPCNL) in managing nephrolithiasis compared to retrograde intrarenal surgery (RIRS). Methods: 130 adult patients with renal stones (1.5–3 cm) were randomized to F-mPCNL or RIRS. The stone-free rate (SFR) was our primary outcome. Secondary outcomes were the operative time, fluoroscopy time, DJ stent insertion rate, auxiliary procedure needed, hospital stay, complications rate, total cost, and quality of life for both procedures. Results: out of 130 patients in our study, 125 were evaluated and completed the follow-up period. Preoperative data was similar in both groups including stone characteristics. F-mPCNL showed a better SFR of 95.1% compared to 77.8% in the RIRS group (p-value˂0.001), this was associated with less need for additional procedures. F-mPCNL was associated with a shorter operation time of 47.60 ± 14.54 min compared to 59.30 ± 20.10 min in the RIRS group (p-value˂0.001). F-mPCNL showed less radiational exposure and less need for DJ stent insertion than RIRS. The overall complication rate was comparable in both groups, postoperative pain, need for extra doses of analgesics, and hospital stay were higher in the F-mPCNL group. In our study, F-mPCNL was shown to be more cost-effective than RIRS. Conclusion: F-mPCNL showed a superior SFR in treating renal stones compared to RIRS in a single session, with less need for auxiliary procedures, shorter operative time, less radiational exposure, and better quality of life. However, it was associated with slightly more hospital stay and postoperative pain compared to RIRS.


  • Open Access

    Evaluation of monotherapy of Coenzyme Q10, L-carnitine or combined therapy on semen parameters in idiopathic male infertility: A placebo-controlled double blind randomized clinical trial

    by Ahmed Higazy, Waleed Mohammed, M. Esmat, Mohamed Samir

    Antioxidant therapy has been proposed to improve the semen parameters in idiopathic male infertility with no clear consensus on the proper way of management. Our study aimed to evaluate the monotherapy of Coenzyme Q10 (CoQ10), L-Carnitine, or combined therapy on semen parameters in idiopathic male infertility presented with oligoasthenoteratozoospermia (OAT). Two hundred patients presented with OAT were randomly allocated into four equal groups representing CoQ10, L-Carnitine, or combined therapy of both versus placebo. Our primary outcome was to monitor the improvement in semen parameters. The secondary outcomes were to evaluate the impact on the sperm DNA fragmentation (SDF) index and hormonal profile. After 3 months of medical therapy, 174 patients completed the follow-up period. A highly statistically significant difference was monitored in the monotherapy and combination therapy in all semen parameters and SDF index compared to the baseline, while the placebo group failed to show any improvement. A rise in testosterone level and a decrease in luteinizing hormone were seen in the monotherapy and combination therapy, while no change was noted in the placebo group. Prolactin levels showed no change in all groups. Antioxidant therapy improves semen parameters in patients with OAT. A combination therapy of CoQ10 and L-carnitine results in a superior improvement in semen parameters compared to monotherapy in men with idiopathic OAT.


  • Ejaculation-Preserving Transurethral Resection of the Prostate: A Randomized Controlled Trial

    by A.M. Tawfeek, Ahmed Radwan, M. Esmat, Abdelrahman Mohamed Ismail, Karim Omar ElSaeed, Ahmed Higazy

    Objective: To evaluate the efficacy of preserving urethral mucosa around verumontanum in all directions and at the prostatic apex on antegrade ejaculation preservation and early postoperative continence in patients undergoing transurethral resection of the prostate (TURP). Materials and Methods: A randomized controlled trial was conducted in our tertiary center on patients scheduled for TURP. Patients were randomly allocated into two equal groups. Group A represented the control group who underwent conventional TURP, while Group B represented the ejaculation-sparing TURP. Patients were followed up for 3 months postoperatively to evaluate the voiding parameters and the preservation of antegrade ejaculation. Results: A total of 106 patients were evaluated in our study. Both groups were comparable regarding improvement in voiding parameters. Antegrade ejaculation was preserved in 44 patients (83%) of Group B compared with 10 patients (18.9%) in Group A with a highly statistically significant difference ( p < 0.001). Early postoperative urge urinary incontinence was lower in group B (5.7%) compared with (20.8%) in group A, with a statistically significant difference ( p = 0.02). Other perioperative parameters were compared between both groups. Conclusion: The ejaculation-sparing technique adopted in our study showed a promising result for preserving antegrade ejaculation following TURP with a success rate of 83%. Additionally, there was a lower incidence of early postoperative urge urinary incontinence.


  • Neutrophils to lymphocytes ratio as a predictor of BCG response in non-muscle invasive bladder cancer

    by Ahmed Higazy, Amr Elsawy, Ahmed Lofty, Hany M Abdallah, Ahmed Radwan

    Aim: To evaluate the role of preoperative neutrophils to lymphocytes ratio (NLR) as a predictor for the response to BCG in patients with non-muscle invasive bladder cancer (NMIBC). Materials: Nighty six patients with NMIBC were prospectively included in our study. Our study population was classified into two groups, based on pre-operative (NLR) either ⩽ or > 3. After receiving BCG, patients were followed up for 3 years to evaluate the correlation between BCG failure and (NLR). Results: Nighty two patients were evaluated at the end of our study. The NLR > 3 group of patients showed a higher age and T stage compared to the NLR ⩽ 3 group with a significant difference. BCG failure was reported to be higher in the NLR > 3 group with a failure rate of 66.7% compared to 28.3% in the other group ( p -value < 0.001). Time to failure in NLR > 3 group compared to NLR ⩽ 3 group was 10.44 ± 4.3 and 15 ± 3.9 months respectively with a ( p -value = 0.002). Univariate and multivariate logistic regression revealed that the most significant predictors of BCG failure were NLR > 3, Initial T stage, and age respectively. Conclusion: BCG response is highly affected by the NLR, with a higher failure rate with NLR > 3.


  • Open Access

    Effect of preoperative Silodosin on facilitating access sheath placement in retrograde intrarenal surgery. A randomized controlled studys

    by Ahmed Higazy, Mohamed Samir, Ahmed AbdelGhani, A.M. Tawfeek, Ahmed Radwan

    To evaluate the effect of preoperative Silodosin on ureteric dilatation to facilitate ureteral access sheath (UAS) placement and reduction of ureteral wall injury in retrograde intrarenal surgery (RIRS). one hundred and twenty patients with renal or ureteric stones were randomly allocated into 2 equal groups. Group A represents patients who received a 7-day preoperative single dose Silodosin before RIRS while Group B represents patients who received a placebo for the same regimen. Our primary outcome was to assess the success rate of (UAS) placement. Our secondary outcomes were to evaluate the perioperative complication rate, stone-free rate, hospital stay, and cost analysis. In our study, Silodosin showed a higher success rate for (UAS) insertion compared to placebo with a statistically significant difference (p-value = 0.04). Spontaneous UAS insertion in the Silodosin group was 58.3%, which was increased with active ureteric dilatation to 98.3%. Preoperative Silodosin led to less postoperative pain and analgesics requirements without impacting postoperative hospital stay or stone-free rate. There was less ureteric injury incidence in the Silodosin group compared to placebo with a statistically significant difference (p-value = 0.002). Preoperative Silodosin facilitates UAS insertion with a protective role against ureteric injury compared to placebo.